{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:49:44Z","timestamp":1791985784855,"version":"4.4.0"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Neovascular glaucoma (NVG) is a severe and refractory form of secondary glaucoma characterized by the proliferation of abnormal vessels in the anterior segment, leading to a progressive rise in intraocular pressure (IOP) and optic nerve damage. It is most commonly associated with ischemic retinal conditions such as diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome. This review aims to provide an updated overview of the current management strategies for NVG, including recent advancements in medical, laser, and surgical treatment modalities. While anti-vascular endothelial growth factor (VEGF) agents have revolutionized early NVG management, panretinal photocoagulation (PRP) remains the cornerstone of ischemia management, with enhancements in laser delivery improving efficacy and safety. Filtration surgeries like trabeculectomy and glaucoma drainage devices offer equivocal results in NVG, and on the other hand, safer cyclodestructive methods like transscleral micropulse and endoscopic cyclophotocoagulation (ECP) have emerged as promising alternatives with reduced complications. The management of NVG requires a multimodal approach involving the primary physician, retina specialist, and a glaucoma specialist with treatment tailored to disease severity and underlying retinal pathology. Further research is needed to optimize treatment algorithms and explore emerging therapies for this challenging condition.<\/jats:p>","DOI":"10.4103\/ijo.ijo_841_25","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:00:33Z","timestamp":1758801633000},"page":"1412-1421","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Updates in the treatment of neovascular glaucoma: From conventional approaches to novel therapies"],"prefix":"10.4103","volume":"73","author":[{"given":"Saurabh","family":"Verma","sequence":"first","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Midha","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Avantika Eye Care and Glaucoma Services, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemlata","family":"Udenia","sequence":"additional","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuj","family":"Dada","sequence":"additional","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/ijo.IJO_1591_20","article-title":"Neovascular glaucoma-A review","volume":"69","author":"Senthil","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08820530902800801","article-title":"Neovascular glaucoma: Etiology, diagnosis and prognosis","volume":"24","author":"Shazly","year":"2009","journal-title":"Semin Ophthalmol"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1167\/iovs.13-11950","article-title":"The prevalence and types of glaucoma in an urban Indian population: The Singapore Indian Eye Study","volume":"54","author":"Narayanaswamy","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4103\/0301-4738.191497","article-title":"Prevalence of glaucoma in Eastern India: The Hooghly River Glaucoma Study","volume":"64","author":"Paul","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1755-3768.1971.tb00954.x","article-title":"The frequency of rubeosis iridis in diabetic patients","volume":"49","author":"Ohrt","year":"1971","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R7-20260420","first-page":"58","article-title":"[Neovascular glaucoma--retrospective study]","volume":"49","author":"Mocanu","year":"2005","journal-title":"Oftalmologia"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3341\/kjo.2016.0067","article-title":"Clinical features of ocular ischemic syndrome and risk factors for neovascular glaucoma","volume":"31","author":"Kim","year":"2017","journal-title":"Korean J Ophthalmol"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/IJG.0000000000002497","article-title":"The burden and clinical features of neovascular glaucoma in a major tertiary care center in China","volume":"34","author":"Lin","year":"2025","journal-title":"J Glaucoma"},{"issue":"Suppl 1","key":"R10-20260420","first-page":"1","article-title":"European Glaucoma Society Terminology and Guidelines for Glaucoma","volume":"105","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40942-016-0051-x","article-title":"Neovascular glaucoma: A review","volume":"2","author":"Rodrigues","year":"2016","journal-title":"Int J Retin Vitr"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000310421","article-title":"Comparison between efficacy of full- and mild-scatter (Panretinal) photocoagulation on the course of diabetic rubeosis iridis","volume":"207","author":"\u0160triga","year":"1993","journal-title":"Ophthalmologica"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00006982-200603000-00024","article-title":"Semiautomated patterned scanning laser for retinal photocoagulation","volume":"26","author":"Blumenkranz","year":"2006","journal-title":"Retina"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1111\/j.1755-3768.2010.02017.x","article-title":"Focal and panretinal photocoagulation with a navigated laser (NAVILAS (R))","volume":"89","author":"Kernt","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"807687","DOI":"10.3389\/fendo.2022.807687","article-title":"Effectiveness of panretinal photocoagulation plus intravitreal anti-VEGF treatment against PRP alone for diabetic retinopathy: A systematic review with meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamaophthalmol.2024.3283","article-title":"Initial therapy of panretinal photocoagulation vs anti-VEGF injection for proliferative diabetic retinopathy","volume":"142","author":"Alsoudi","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00006982-199717050-00010","article-title":"Peripheral transscleral retinal diode laser for rubeosis iridis","volume":"17","author":"Flaxel","year":"1997","journal-title":"Retina"},{"key":"R18-20260420","first-page":"256","article-title":"A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma","volume":"22","author":"Sihota","year":"1991","journal-title":"Ophthalmic Surg"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/jop.2013.0104","article-title":"Anterior retinal cryotherapy and intravitreal injection of bevacizumab in the treatment of nonclearing vitreous hemorrhage in proliferative diabetic retinopathy","volume":"30","author":"Hsieh","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/jpm14010018","article-title":"Clinical efficacy of preoperative and intraoperative intravitreal ranibizumab as adjuvant therapy of ahmed glaucoma valve implantation combined with vitrectomy in the management of neovascular glaucoma with diabetic vitreous hemorrhage","volume":"14","author":"Gao","year":"2023","journal-title":"J Pers Med"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s004170050332","article-title":"Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma","volume":"237","author":"Bartz-Schmidt","year":"1999","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0002-9394(99)00363-3","article-title":"Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma","volume":"129","author":"Scott","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.aopr.2023.05.001","article-title":"Outcomes of vitrectomy, complete pan-retinal photocoagulation, and endoscopic cyclophotocoagulation surgery after anti-VEGF treatment in neovascular glaucoma","volume":"3","author":"Li","year":"2023","journal-title":"Adv Ophthalmol Pract Res"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-9233.53865","article-title":"Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma","volume":"16","author":"Ghanem","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3341\/kjo.2017.0017","article-title":"Efficacy and safety of intracameral bevacizumab for treatment of neovascular glaucoma","volume":"31","author":"Ha","year":"2017","journal-title":"Korean J Ophthalmol"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s10792-022-02265-x","article-title":"Clinical observation of ranibizumab combined with surgery in the treatment of neovascular glaucoma with vitreous hemorrhage","volume":"42","author":"Li","year":"2022","journal-title":"Int Ophthalmol"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00417-013-2428-y","article-title":"Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma\u2014results from a prospective interventional case series","volume":"251","author":"L\u00fcke","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s12325-020-01579-5","article-title":"Intravitreal aflibercept in Japanese patients with neovascular glaucoma: The VEGA randomized clinical trial","volume":"38","author":"Inatani","year":"2021","journal-title":"Adv Ther"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/ceo.12559","article-title":"Aflibercept for the treatment of neovascular glaucoma","volume":"43","author":"SooHoo","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12886-017-0554-8","article-title":"Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: A real-life clinical practice study","volume":"17","author":"Xu","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.18240\/ijo.2023.07.21","article-title":"Comparison of efficacy of conbercept, aflibercept, and ranibizumab ophthalmic injection in the treatment of macular edema caused by retinal vein occlusion: A meta-analysis","volume":"16","author":"Xing","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"e080103","DOI":"10.1136\/bmjopen-2023-080103","article-title":"Comparative efficacy and safety of different anti-VEGF agents combined with different delivery methods for neovascular glaucoma: A systematic review and Bayesian network meta-analysis","volume":"14","author":"Wang","year":"2024","journal-title":"BMJ Open"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jop.2018.0093","article-title":"Conbercept and ranibizumab pretreatments in vitrectomy with silicone oil infusion for severe diabetic retinopathy","volume":"35","author":"Yang","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s10792-021-01846-6","article-title":"Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma","volume":"41","author":"Guo","year":"2021","journal-title":"Int Ophthalmol"},{"key":"R35-20260420","first-page":"68","article-title":"Comparison between the efficacy and side effects of intravitreal versus anterior chamber Bevacizumab injection in neovascular glaucoma patients","volume":"7","author":"Ungureanu","year":"2014","journal-title":"J Med Life"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/IJG.0b013e318294865c","article-title":"Ocular decompression with cotton swabs lowers intraocular pressure elevation after intravitreal injection","volume":"23","author":"Gregori","year":"2014","journal-title":"J Glaucoma"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5005\/jp-journals-10008-1132","article-title":"Intraocular pressure rise after anti-VEGF treatment: Prevalence, possible mechanisms and correlations","volume":"7","author":"Kampougeris","year":"2013","journal-title":"J Curr Glaucoma Pract"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40942-019-0157-z","article-title":"Anterior chamber paracentesis during intravitreal injections in observational trials: Effectiveness and safety and effects","volume":"5","author":"Saxena","year":"2019","journal-title":"Int J Retina Vitreous"},{"key":"R39-20260420","first-page":"101","article-title":"Use of Rho kinase inhibitors in ophthalmology: A review of the literature","volume":"7","author":"Moshirfar","year":"2018","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0161-6420(95)30938-4","article-title":"5-fluorouracil filtering surgery and neovascular glaucoma","volume":"102","author":"Tsai","year":"1995","journal-title":"Ophthalmology"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3341\/kjo.2001.15.2.98","article-title":"Midd-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients","volume":"15","author":"Hyung","year":"2001","journal-title":"Korean J Ophthalmol"},{"key":"R42-20260420","first-page":"287","article-title":"Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report","volume":"50","author":"Mandal","year":"2002","journal-title":"Indian J Ophthalmol"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0161-6420(03)00785-1","article-title":"Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery","volume":"110","author":"Katz","year":"2003","journal-title":"Ophthalmology"},{"key":"R44-20260420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1755-3768.2009.01648.x","article-title":"Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma","volume":"88","author":"Saito","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R45-20260420","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.12.9.12","article-title":"Short-term outcomes of trabeculectomy with or without anti-VEGF in patients with neovascular glaucoma: A systematic review and meta-analysis","volume":"12","author":"Zhou","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"R46-20260420","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/IJG.0b013e3181d9ce12","article-title":"Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma","volume":"20","author":"Takihara","year":"2011","journal-title":"J Glaucoma"},{"key":"R47-20260420","doi-asserted-by":"crossref","first-page":"1405261","DOI":"10.3389\/fmed.2024.1405261","article-title":"The efficacy and safety of anti-vascular endothelial growth factor combined with Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma: A systematic review and meta-analysis","volume":"11","author":"He","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/IJG.0000000000000241","article-title":"Clinical outcomes of ahmed glaucoma valve implantation with or without intravitreal bevacizumab pretreatment for neovascular glaucoma: A systematic review and meta-analysis","volume":"25","author":"Zhou","year":"2016","journal-title":"J Glaucoma"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.eye.6702125","article-title":"Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma","volume":"21","author":"Yalvac","year":"2007","journal-title":"Eye"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.survophthal.2004.10.006","article-title":"Glaucoma drainage devices: A systematic literature review and current controversies","volume":"50","author":"Hong","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0161-6420(95)30904-9","article-title":"Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma","volume":"102","author":"Sidoti","year":"1995","journal-title":"Ophthalmology"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0161-6420(93)31557-5","article-title":"Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome","volume":"100","author":"Mermoud","year":"1993","journal-title":"Ophthalmology"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/IJG.0b013e31820e2fd0","article-title":"Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma","volume":"21","author":"Ma","year":"2012","journal-title":"J Glaucoma"},{"key":"R54-20260420","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/IJG.0b013e318259aec4","article-title":"Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma","volume":"22","author":"Mahdy","year":"2013","journal-title":"J Glaucoma"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3760\/cma.j.issn.0366-6999.20130011","article-title":"Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma","volume":"126","author":"Zhou","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10792-013-9875-7","article-title":"The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma","volume":"34","author":"Kang","year":"2014","journal-title":"Int Ophthalmol"},{"key":"R57-20260420","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/aos.12493","article-title":"Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up","volume":"93","author":"Arcieri","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R58-20260420","doi-asserted-by":"crossref","first-page":"7672485","DOI":"10.1155\/2017\/7672485","article-title":"Effect of preoperative intravitreal bevacizumab on the surgical outcome of neovascular glaucoma at different stages","volume":"2017","author":"Kwon","year":"2017","journal-title":"J Ophthalmol"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s12325-025-03128-4","article-title":"Surgical outcomes of Baerveldt glaucoma implant versus ahmed glaucoma valve in neovascular glaucoma: A retrospective multicenter study","volume":"42","author":"Iwasaki","year":"2025","journal-title":"Adv Ther"},{"key":"R60-20260420","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/IJG.0000000000001953","article-title":"Three-year outcomes of Pars Plana Ahmed and Baerveldt glaucoma implantations for neovascular glaucoma in Japanese eyes","volume":"31","author":"Maeda","year":"2022","journal-title":"J Glaucoma"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"26","DOI":"10.14744\/bej.2024.96729","article-title":"Assessing the efficacy of the PAUL glaucoma implant in pseudoexfoliative glaucoma","volume":"9","author":"Olgun","year":"2024","journal-title":"Beyoglu Eye J"},{"key":"R62-20260420","first-page":"281","article-title":"Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma","volume":"5","author":"Shen","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R63-20260420","first-page":"400","article-title":"Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma","volume":"10","author":"Sun","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"R64-20260420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12886-016-0248-7","article-title":"Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: Assessment of efficacy and complications","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"R65-20260420","doi-asserted-by":"crossref","first-page":"101668","DOI":"10.1016\/j.ajoc.2022.101668","article-title":"Gonioscopy-assisted transluminal trabeculotomy in neovascular glaucoma: Salvaging the conventional outflow pathway","volume":"28","author":"Kanter","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R66-20260420","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1755-3768.2010.01918.x","article-title":"Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema","volume":"89","author":"Yilmaz","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/APO.0000000000000248","article-title":"Intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy versus visco-trabeculotomy in management of neovascular glaucoma","volume":"8","author":"Elwehidy","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R68-20260420","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/IIO.0000000000000492","article-title":"Cyclophotocoagulation as a minimally invasive treatment option for glaucoma","volume":"63","author":"Khodeiry","year":"2023","journal-title":"Int Ophthalmol Clin"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","article-title":"Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma","volume":"38","author":"Tan","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"R70-20260420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1120672119877586","article-title":"Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction","volume":"31","author":"Souissi","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/IJG.0000000000001174","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients","volume":"28","author":"Zaarour","year":"2019","journal-title":"J Glaucoma"},{"key":"R72-20260420","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3892\/etm.2022.11207","article-title":"Micropulse vs. continuous wave transscleral cyclophotocoagulation in neovascular glaucoma","volume":"23","author":"Zemba","year":"2022","journal-title":"Exp Ther Med"},{"key":"R73-20260420","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/IJG.0b013e31817d235c","article-title":"A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: A long-term follow-up","volume":"18","author":"Yildirim","year":"2009","journal-title":"J Glaucoma"},{"key":"R74-20260420","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2147\/OPTH.S188999","article-title":"Randomized comparative trial of diode laser transscleral cyclophotocoagulation versus Ahmed glaucoma valve for neovascular glaucoma in Chinese-A pilot study","volume":"12","author":"Choy","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R75-20260420","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/biomedicines12010186","article-title":"Endocyclophotocoagulation combined with phacoemulsification in glaucoma treatment: Five-year results","volume":"12","author":"Bolek","year":"2024","journal-title":"Biomedicines"},{"key":"R76-20260420","doi-asserted-by":"crossref","first-page":"100074","DOI":"10.1016\/j.apjo.2024.100074","article-title":"Long-term efficacy and safety of posterior endoscopic cyclophotocoagulation in refractory glaucoma: A 5-year follow-up study at a tertiary eye center","volume":"13","author":"Fang","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R77-20260420","doi-asserted-by":"crossref","first-page":"e0234798","DOI":"10.1371\/journal.pone.0234798","article-title":"Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma","volume":"15","author":"Cheng","year":"2020","journal-title":"PLoS One"},{"key":"R78-20260420","doi-asserted-by":"crossref","first-page":"9938928","DOI":"10.1155\/2021\/9938928","article-title":"Efficacy and safety of combined surgeries including intraocular direct cyclophotocoagulation with a 532 nm laser to treat advanced neovascular glaucoma","volume":"2021","author":"Chen","year":"2021","journal-title":"J Ophthalmol"},{"key":"R79-20260420","doi-asserted-by":"crossref","first-page":"4016536","DOI":"10.1155\/2020\/4016536","article-title":"A comparative study between ultrasound cycloplasty and cyclocryotherapy for the treatment of neovascular glaucoma","volume":"2020","author":"Ruixue","year":"2020","journal-title":"J Ophthalmol"},{"key":"R80-20260420","doi-asserted-by":"crossref","first-page":"23073","DOI":"10.1038\/s41598-023-50157-6","article-title":"A comparative study of ultrasound cycloplasty and endoscopic cyclophotocoagulation in the treatment of secondary glaucoma","volume":"13","author":"Ruixue","year":"2023","journal-title":"Sci Rep"},{"key":"R81-20260420","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12886-020-01655-y","article-title":"Comparison of ultrasound cycloplasty and transscleral cyclophotocoagulation for refractory glaucoma in Chinese population","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R82-20260420","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/IJG.0000000000001796","article-title":"Efficacy and safety of ultrasound cycloplasty for refractory glaucoma: A 3-year study","volume":"30","author":"Rouland","year":"2021","journal-title":"J Glaucoma"},{"key":"R83-20260420","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/aos.15754","article-title":"Efficacy and safety of transscleral cyclophotocoagulation versus cyclocryotherapy in the treatment of intractable glaucoma: A systematic review and meta-analysis","volume":"102","author":"Wang","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"R84-20260420","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s12325-018-0837-3","article-title":"Cyclodestructive procedures in glaucoma: A review of current and emerging options","volume":"35","author":"Dastiridou","year":"2018","journal-title":"Adv Ther"},{"key":"R85-20260420","doi-asserted-by":"crossref","first-page":"100136","DOI":"10.1016\/j.apjo.2025.100136","article-title":"Treatment modalities and trends for hospitalized patients with neovascular glaucoma: A retrospective study of 10 years","volume":"14","author":"Lin","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"Suppl 2","key":"R86-20260420","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.4103\/IJO.IJO_3145_23","article-title":"Long-term outcome of surgical management in neovascular glaucoma: A retrospective, multicentric study","volume":"73","author":"Pegu","year":"2025","journal-title":"Indian J Ophthalmol"},{"key":"R87-20260420","doi-asserted-by":"crossref","first-page":"e051794","DOI":"10.1136\/bmjopen-2021-051794","article-title":"Comparisons of the short-term effectiveness and safety of surgical treatment for neovascular glaucoma: A systematic review and network meta-analysis","volume":"12","author":"Lin","year":"2022","journal-title":"BMJ Open"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_841_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:25:58Z","timestamp":1786724758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_841_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_841_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"2025-03-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}